Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  318 results for "%22AUSTRALIA%22"

Your Filters

Publication : diabetes care Subject : biomarkers Subject : diabetes mellitus, type 2 Subject : glucose intolerance Subject : insulin-secreting cells Subject : renal insufficiency, chronic Subject : self-management Subject : sodium-glucose transporter 2 inhibitors Filter by : Author
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study.

  • Authors : Beernink JM; 1Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Persson F

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Heart Failure*/Heart Failure*/Heart Failure*/complications ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications

  • Source: Diabetes care [Diabetes Care] 2023 Mar 01; Vol. 46 (3), pp. 602-607.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial.

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/prevention & control ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: Diabetes care [Diabetes Care] 2021 Aug; Vol. 44 (8), pp. 1894-1897. Date of Electronic Publication: 2021 Jun 28.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.

  • Authors : Peters KE; Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Fremantle, Western Australia, Australia.; Proteomics International, Perth, Western Australia, Australia.

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*blood ; Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/*blood

  • Source: Diabetes care [Diabetes Care] 2017 Nov; Vol. 40 (11), pp. 1548-1555. Date of Electronic Publication: 2017 Aug 29.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE Trials.

  • Authors : Tobe SW; Sunnybrook Research Institute, Toronto, Ontario, Canada.; Northern Ontario School of Medicine, Sudbury, Ontario, Canada.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

  • Source: Diabetes care [Diabetes Care] 2024 Mar 01; Vol. 47 (3), pp. 501-507.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium-Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction.

  • Authors : Umapathysivam MM; Southern Adelaide Diabetes and Endocrine Services, Flinders Medical Centre, Adelaide, South Australia, Australia.; Endocrine Department, Queen Elizabeth Hospital, Woodville South, South Australia, Australia.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetic Ketoacidosis*/Diabetic Ketoacidosis*/Diabetic Ketoacidosis*/chemically induced

  • Source: Diabetes care [Diabetes Care] 2024 Jan 01; Vol. 47 (1), pp. 140-143.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

SGLT2 Inhibitor-Induced Ketoacidosis in a Patient Without Diabetes.

  • Authors : Hayes AG; Department of Diabetes and Endocrinology, St Vincent's Hospital, Sydney, Australia.; Raven LM

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetic Ketoacidosis*/Diabetic Ketoacidosis*/Diabetic Ketoacidosis*/chemically induced ; Ketosis*/Ketosis*/Ketosis*/chemically induced

  • Source: Diabetes care [Diabetes Care] 2024 Jan 01; Vol. 47 (1), pp. e4-e5.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Effect of Conventional Lifestyle Interventions on Type 2 Diabetes Incidence by Glucose-Defined Prediabetes Phenotype: An Individual Participant Data Meta-analysis of Randomized Controlled Trials.

  • Authors : Sathish T; Department of Family and Preventive Medicine, School of Medicine, Emory University, Atlanta, GA.; Emory Global Diabetes Research Center, Woodruff Health Sciences Center, Emory University, Atlanta, GA.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/prevention & control ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/etiology

  • Source: Diabetes care [Diabetes Care] 2023 Nov 01; Vol. 46 (11), pp. 1903-1907.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Does the Effect of a 3-Year Lifestyle Intervention on Body Weight and Cardiometabolic Health Differ by Prediabetes Metabolic Phenotype? A Post Hoc Analysis of the PREVIEW Study.

  • Authors : Zhu R; Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.; Jalo E

Subjects: Prediabetic State*/Prediabetic State*/Prediabetic State*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Glucose Intolerance*

  • Source: Diabetes care [Diabetes Care] 2022 Nov 01; Vol. 45 (11), pp. 2698-2708.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS.

  • Authors : Koshino A; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.; Department of Nephrology and Laboratory Medicine, Kanazawa University, Ishikawa, Japan.

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

  • Source: Diabetes care [Diabetes Care] 2022 Nov 01; Vol. 45 (11), pp. 2644-2652.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Clinical Utility of Cardiovascular Risk Scores for Identification of People With Type 2 Diabetes More Likely to Benefit From Either GLP-1 Receptor Agonist or SGLT2 Inhibitor Therapy.

  • Authors : Sacre JW; Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Australia.; Magliano DJ

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists

  • Source: Diabetes care [Diabetes Care] 2022 Aug 01; Vol. 45 (8), pp. 1900-1906.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  318 results for "%22AUSTRALIA%22"